# A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE

> **NCT00933556** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 90 (actual)

## Conditions studied

- Anti-biotic Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3
- **DIETARY_SUPPLEMENT:** sugar pill (placebo)

## Key facts

- **NCT ID:** NCT00933556
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-10
- **Final completion:** 2012-03
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933556, "A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00933556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*